Angela Specht, MBA is the Global Head, BARDA Alliance for Johnson & Johnson Innovation. In this role, Angela leads BLUE KNIGHT™, a joint initiative between JLABS and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services. BLUE KNIGHT™ aims to stimulate the innovation and incubation of science and technologies that may improve health security and accelerate development in areas of mutual areas of interest for BARDA and Johnson & Johnson. Angela is an experienced and passionate pharmaceutical executive with 20 years of experience in the health care industry. In her two decades with Johnson & Johnson, she has had the privilege of holding leadership roles in finance, strategy and commercial functions across Johnson & Johnson Innovation, Johnson & Johnson Development Corp (JJDC), Johnson & Johnson Global Public Health, and Johnson & Johnson Innovative Medicines. She also served as co-chair of the Johnson & Johnson Enterprise Governance Council, where she shaped the enterprise-level sustainability strategy and goals, and she serves on the finance committee of the StopTB Partnership. Angela earned an MBA from the Wharton School of Business and earned her bachelor’s degree in Accounting from The Pennsylvania State University.